FIELD: chemistry.
SUBSTANCE: present invention relates to an imidazopyridazine compound by the chemical Formula 1, wherein, in the chemical Formula 1: R1 represents halogen, L represents -CH=CH-, R2 represents -O-(CH2)n-, n is an integer from 1 to 3, W represents a saturated 6-membered unsubstituted or substituted with a hydroxy group monocyclic heterocycloalkyl containing 1 N atom, and R3 represents H or hydroxy. Also proposed is a pharmaceutical composition exhibiting inhibitory activity against the growth of SK-CO-1 cell, containing a compound by the chemical Formula 1 as an active ingredient.
EFFECT: proposed imidazopyridazine compound has a high inhibitory activity against cell growth and, thus, can be successfully applied as a preventive or therapeutic agent against cancer or a tumour.
Chemical Formula 1
5 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING DIHYDROINDENAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND USING THEM AS PROTEIN KINASE INHIBITOR | 2009 |
|
RU2528408C2 |
N-7 SUBSTITUTED PURINES AND PYRAZOLOPYRIMIDINES, COMPOSITIONS THEREOF AND METHODS FOR USE | 2010 |
|
RU2515541C2 |
NOVEL COMPOUND OF 2,3,5-SUBSTITUTED THIOPHENE AS A PROTEIN KINASE INHIBITOR | 2017 |
|
RU2724957C2 |
COMPOUND BASED ON DIHYDRONAPTHYRIDINONE, METHOD OF ITS OBTAINING, AND ITS USE IN MEDICINE | 2021 |
|
RU2809869C1 |
IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES | 2009 |
|
RU2518089C2 |
IMIDAZO[1,2-b]PYRIDAZINE AND PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND USE THEREOF AS PROTEIN KINASE INHIBITOR | 2007 |
|
RU2487875C2 |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES, POSSESSING INHIBITING ACTION WITH RESPECT TO PROTEINKINASE | 2011 |
|
RU2524210C2 |
NEW COMPOUND AS A PROTEIN KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUND | 2019 |
|
RU2785734C1 |
DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
NEW QUINOLINE COMPOUNDS | 2018 |
|
RU2810113C2 |
Authors
Dates
2022-01-25—Published
2018-01-23—Filed